We are pleased to announce that our research project D&S-AI, in collaboration with the Biomedical Research and Innovation Institute of Cádiz INiBICA, has achieved exceptional results in the early and accurate detection of COVID-19 using artificial intelligence.
Key Achievements:
- We developed a predictive algorithm that combines an optimized questionnaire and antigen tests.
- We achieved 87% accuracy in predicting PCR results, with a sensitivity of 94.6%.
- Our model can diagnose 92 out of 100 patients with COVID-19 using only a 10-question questionnaire.
Collaborations:
- Close collaboration with INiBICA and university hospitals in Cádiz.
- Funding from the Ministry of Health and Consumer Affairs of the Andalusian Regional Government.
Interested in being part of this digital health revolution?
Contact us for more information on investment and collaboration opportunities! We are seeking an investment of €8M, with an initial round of €1.5M, to expand our capabilities and reach the global market.
Based on the success of D&S-AI we’ve developed PathogenIA: A new AI tool, designed to:
- Assist in managing respiratory infections
- Predict whether the origin is bacterial or viral
- Reduce unnecessary antibiotic prescriptions
Our founder, Sebastian Armijos, and the entire E Process Med team are committed to transforming primary care and combating antibiotic resistance. For collaborations please contact Sebastian.armijos@e-processmed.com
We deeply appreciate the valuable collaboration of Dr. Alberto Romero Palacios and the entire INiBICA team. We also express our gratitude to Emprendedores journal, especially to the Editorial team Pilar Ponce de León and Javier Muñoz. Link to article: El programa de investigación D&S-AI logra una detección temprana y más precisa de la COVID-19 a través de IA (emprendedores.es)
e-Process Med
Medical digitalisation, Patient empowerment, Blockchain, Artificial intelligence.
